Eisenhauer E - Search Results

1

A randomized phase II and pharmacokinetic study of the antisense oligonucleotides ISIS 3521 and ISIS 5132 in patients with hormone-refractory prostate cancer.

Tolcher AW, Reyno L, Venner PM, Ernst SD, Moore M, Geary RS, Chi K, Hall S, Walsh W, Dorr A, Eisenhauer E. Tolcher AW, et al. Among authors: eisenhauer e. Clin Cancer Res. 2002 Aug;8(8):2530-5. Clin Cancer Res. 2002. PMID: 12171880 Clinical Trial.

2

Phase II randomized study of ISIS 3521 and ISIS 5132 in patients with locally advanced or metastatic colorectal cancer: a National Cancer Institute of Canada clinical trials group study.

Cripps MC, Figueredo AT, Oza AM, Taylor MJ, Fields AL, Holmlund JT, McIntosh LW, Geary RS, Eisenhauer EA. Cripps MC, et al. Clin Cancer Res. 2002 Jul;8(7):2188-92. Clin Cancer Res. 2002. PMID: 12114419 Clinical Trial.

3

Phase II trial of OGX-011 in combination with docetaxel in metastatic breast cancer.

Chia S, Dent S, Ellard S, Ellis PM, Vandenberg T, Gelmon K, Powers J, Walsh W, Seymour L, Eisenhauer EA. Chia S, et al. Clin Cancer Res. 2009 Jan 15;15(2):708-13. doi: 10.1158/1078-0432.CCR-08-1159. Clin Cancer Res. 2009. PMID: 19147778 Clinical Trial.

4

A phase I study of OGX-011, a 2'-methoxyethyl phosphorothioate antisense to clusterin, in combination with docetaxel in patients with advanced cancer.

Chi KN, Siu LL, Hirte H, Hotte SJ, Knox J, Kollmansberger C, Gleave M, Guns E, Powers J, Walsh W, Tu D, Eisenhauer E. Chi KN, et al. Among authors: eisenhauer e. Clin Cancer Res. 2008 Feb 1;14(3):833-9. doi: 10.1158/1078-0432.CCR-07-1310. Clin Cancer Res. 2008. PMID: 18245546 Clinical Trial.

5

Randomized phase II study of docetaxel and prednisone with or without OGX-011 in patients with metastatic castration-resistant prostate cancer.

Chi KN, Hotte SJ, Yu EY, Tu D, Eigl BJ, Tannock I, Saad F, North S, Powers J, Gleave ME, Eisenhauer EA. Chi KN, et al. Among authors: eisenhauer ea. J Clin Oncol. 2010 Sep 20;28(27):4247-54. doi: 10.1200/JCO.2009.26.8771. Epub 2010 Aug 23. J Clin Oncol. 2010. PMID: 20733135 Clinical Trial.

6

A phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2'-methoxyethyl antisense oligonucleotide to clusterin, in patients with localized prostate cancer.

Chi KN, Eisenhauer E, Fazli L, Jones EC, Goldenberg SL, Powers J, Tu D, Gleave ME. Chi KN, et al. Among authors: eisenhauer e. J Natl Cancer Inst. 2005 Sep 7;97(17):1287-96. doi: 10.1093/jnci/dji252. J Natl Cancer Inst. 2005. PMID: 16145049 Clinical Trial.

7

Randomized phase II study of high-dose paclitaxel with or without amifostine in patients with metastatic breast cancer.

Gelmon K, Eisenhauer E, Bryce C, Tolcher A, Mayer L, Tomlinson E, Zee B, Blackstein M, Tomiak E, Yau J, Batist G, Fisher B, Iglesias J. Gelmon K, et al. Among authors: eisenhauer e. J Clin Oncol. 1999 Oct;17(10):3038-47. doi: 10.1200/JCO.1999.17.10.3038. J Clin Oncol. 1999. PMID: 10506598 Clinical Trial.

8

Phase I and pharmacologic study of the human DNA methyltransferase antisense oligodeoxynucleotide MG98 given as a 21-day continuous infusion every 4 weeks.

Davis AJ, Gelmon KA, Siu LL, Moore MJ, Britten CD, Mistry N, Klamut H, D'Aloisio S, MacLean M, Wainman N, Ayers D, Firby P, Besterman JM, Reid GK, Eisenhauer EA. Davis AJ, et al. Invest New Drugs. 2003 Feb;21(1):85-97. doi: 10.1023/a:1022976528441. Invest New Drugs. 2003. PMID: 12795533 Clinical Trial.

9

Gemcitabine in advanced renal cell carcinoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group.

Mertens WC, Eisenhauer EA, Moore M, Venner P, Stewart D, Muldal A, Wong D. Mertens WC, et al. Among authors: eisenhauer ea. Ann Oncol. 1993 Apr;4(4):331-2. doi: 10.1093/oxfordjournals.annonc.a058494. Ann Oncol. 1993. PMID: 8518225 Free article. Clinical Trial.

10

Phase I dose-finding study of a new taxane, RPR 109881A, administered as a one-hour intravenous infusion days 1 and 8 to patients with advanced solid tumors.

Gelmon KA, Latreille J, Tolcher A, Génier L, Fisher B, Forand D, D'Aloisio S, Vernillet L, Daigneault L, Lebecq A, Besenval M, Eisenhauer E. Gelmon KA, et al. Among authors: eisenhauer e. J Clin Oncol. 2000 Dec 15;18(24):4098-108. doi: 10.1200/JCO.2000.18.24.4098. J Clin Oncol. 2000. PMID: 11118471 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

388 results

Search Page

Filters